Agilent Completes Acquisition of BIOVECTRA

SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO) that specializes in biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics. Read More

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
DIRTT Announces Results of Special Meeting of Shareholders
NDP asks competition watchdog to probe potential rent-fixing by corporate landlords

Amazon says workers need to be in the office. Most of Silicon Valley disagrees
LEADING EDGE REPORTS QUARTERLY RESULTS TO JULY 31, 2024